A Sudbury doctor and Laurentian University professor has launched a clinical trial for breast cancer, expected to determine early on which patients are responding to chemotherapy treatment. He stated in a press release today that the clinical trials will include more than 500 patients across Europe and North America who have invasive breast cancer. An 'obvious need' for this type of diagnostic"For breast cancer, on average, about 70 per cent of patients don't get a survival benefit," he said. And pending reports of another publication, Parissenti said this type of diagnostic may be used for other cancer types, not just breast cancer. Personalized treatment solutionsJanet McElhaney, Scientific Director at Health Sciences North, said the launch of the trial is an important step for breast cancer research.

Source: CBC News June 14, 2017 15:17 UTC